Simultaneous interference of SP1 and HIF1α retarding the proliferation, migration, and invasion of human microvascular endothelial cells (HMEC-1) u…

A new interesting article has been published in J Cell Biochem. 2019 May 28. doi: 10.1002/jcb.29059. and titled: Simultaneous interference of SP1 and HIF1α retarding the proliferation, migration, and invasion…

Continue Reading Simultaneous interference of SP1 and HIF1α retarding the proliferation, migration, and invasion of human microvascular endothelial cells (HMEC-1) u…

The coexistence of a novel WNK1 variant and a copy number variation causes hereditary sensory and autonomic neuropathy type IIA.

A new interesting article has been published in BMC Med Genet. 2019 May 27;20(1):91. doi: 10.1186/s12881-019-0828-5. and titled: The coexistence of a novel WNK1 variant and a copy number variation…

Continue Reading The coexistence of a novel WNK1 variant and a copy number variation causes hereditary sensory and autonomic neuropathy type IIA.

NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer-An Integrative Multi-Omics Approach.

A new interesting article has been published in Cancers (Basel). 2019 May 20;11(5). pii: E698. doi: 10.3390/cancers11050698. and titled: NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of…

Continue Reading NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer-An Integrative Multi-Omics Approach.

Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.

A new interesting article has been published in Int J Cancer. 2019 May 28. doi: 10.1002/ijc.32481. and titled: Somatic mutations and promotor methylation of the ryanodine receptor 2 is a…

Continue Reading Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.

Implementation of a novel self-induced promoter for the expression of pharmaceutical peptides in Escherichia coli: YY(3-36) peptide.

A new interesting article has been published in Horm Mol Biol Clin Investig. 2019 May 28. pii: /j/hmbci.ahead-of-print/hmbci-2018-0056/hmbci-2018-0056.xml. doi: 10.1515/hmbci-2018-0056. and titled: Implementation of a novel self-induced promoter for the…

Continue Reading Implementation of a novel self-induced promoter for the expression of pharmaceutical peptides in Escherichia coli: YY(3-36) peptide.